Health knowledge made personal
Join this community!
› Share page:
Search posts:

Novel Grant Supports Drug Discovery Effort

Posted Mar 26 2010 2:59pm

A $10 million grant from the National Institute of Mental Health has established Vanderbilt’s Program in Drug Discovery as a National Cooperative Drug Discovery and Development Group (NCDDDG).

The five-year grant will support efforts to find novel therapeutic agents for the treatment of schizophrenia.

“This is one of the first examples of the NIH funding a fully integrated drug discovery effort, with the large team of investigators it takes to move ideas from basic science findings all the way to novel therapeutics,” said P. Jeffrey Conn, Ph.D., director of the Vanderbilt Program in Drug Discovery and co-principal investigator with Craig Lindsley, Ph.D., director of Medicinal Chemistry, of the NCDDDG.

The program’s other leaders — internationally recognized in their respective areas of drug discovery — are Carrie Jones, Ph.D., director of Behavioral Pharmacology, Colleen Niswender, Ph.D., director of Molecular Pharmacology, and J. Scott Daniels, Ph.D., director of Drug Metabolism and Pharmacokinetics.

Post a comment
Write a comment:

Related Searches